Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Fentanyl vs SR-morphine for Chronic Cancer Pain
NCT01906073Phase 3Withdrawn
- Sponsor
- Norwegian University of Science and Technology
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in cancer pain, sponsored by Norwegian University of Science and Technology. Planned start Jan 2017; status: withdrawn.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01906073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906073.